eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Forum Health Products Limited

Forum Health Products Limited, Betchworth House, 57/65 Station Road, Redhill, Surrey, RH1 1DL
Telephone: +44 (0)1737 857 782
Fax: +44 (0) 1737 857701
WWW: http://www.forum.co.uk
Medical Information Direct Line: 0500 455 456
Customer Care direct line: 0500 455 456

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?


Summary of Product Characteristics last updated on the eMC: 02/08/2010
SPC Senokot Syrup


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Senokot Syrup Pharmacy.


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

The syrup contains sennosides USP equivalent to a total sennoside content (calculated as sennoside B) of 7.5 mg per 5 ml.

For excipients, see Section 6.1.


Go to top of the page
3. PHARMACEUTICAL FORM

Syrup.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

In the management of constipation.


Go to top of the page
4.2 Posology and method of administration

Senokot Syrup Pharmacy is for oral administration.

Adults, including the elderly and children over 12: Two to four 5 ml spoonfuls at night.

Children over 6 years: One to two 5 ml spoonfuls in 24 hours.

Children aged 2 to 6 years: Half to one 5 ml spoonful in 24 hours.

New users should start the lowest dose and increase, if necessary, by one half of the initial dose each day. Once regularity has been regained the dosage should be reduced and can usually be stopped.

If no bowel action has occurred after three days of progressively increased dosage, a medical examination should be considered.


Go to top of the page
4.3 Contraindications

Senokot Syrup Pharmacy should not be given when any undiagnosed acute or persistent abdominal symptoms are present.


Go to top of the page
4.4 Special warnings and precautions for use

If there is no bowel movement after three days consult a doctor.

If laxatives are needed every day or abdominal pain persists consult a doctor.

Each 5 ml of syrup can provide up to 3.2 kcal and this should be taken into account when treating diabetics.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

None known.


Go to top of the page
4.6 Pregnancy and lactation

There is some evidence for the safety of senna derived products in human pregnancy which have been in use for many years without apparent ill-consequence. If laxative treatment is required during pregnancy Senokot Syrup Pharmacy may be used. Clinical studies have shown that breast-fed infants of mothers taking senna derived products did not show any significant side-effects.


Go to top of the page
4.7 Effects on ability to drive and use machines

None known.


Go to top of the page
4.8 Undesirable effects

Temporary mild griping may occur during adjustment of the dosage. Hypersensitivity reactions associated with the esters of hydroxybenzoates (parabens) may occur.


Go to top of the page
4.9 Overdose

Where diarrhoea is severe conservative measures are usually sufficient; generous amounts of fluid, especially fruit drinks, should be given.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

The sugar moiety of the sennosides is removed by bacteria in the large intestine releasing the active anthrone fraction. This stimulates peristalsis via the submucosal and myenteric nerve plexuses. Sennosides act in 8 – 12 hours.


Go to top of the page
5.2 Pharmacokinetic properties

The action of the sennosides is colon specific and does not depend upon systemic absorption.


Go to top of the page
5.3 Preclinical safety data

No preclinical findings of relevance to the prescriber have been reported.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Potassium sorbate

Methyl parahydroxybenzoate

Propyl parahydroxybenzoate

Maltitol syrup

Xanthan gum

Anti-foam emulsion

Prune flavour

Citric acid

Purified water


Go to top of the page
6.2 Incompatibilities

None known.


Go to top of the page
6.3 Shelf life

18 months.


Go to top of the page
6.4 Special precautions for storage

Do not store above 25°C. Do not freeze.


Go to top of the page
6.5 Nature and contents of container

Glass bottle with a polypropylene cap with a polyethylene tamper-evident band with an expanded polyethylene wad containing 500 ml syrup.


Go to top of the page
6.6 Special precautions for disposal and other handling

No special instructions.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

Reckitt Benckiser Healthcare (UK) Limited,

Dansom Lane,

Hull,

HU8 7DS.

United Kingdom


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 00063/0129


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

13/10/2009


Go to top of the page
10. DATE OF REVISION OF THE TEXT

13/10/2009



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/6877/SPC/


Active Ingredients/Generics

 
   sennoside